APAC Aquaculture Vaccines Market size is anticipated to exceed USD 37.4 million by 2027, according to a latest forecast report by Graphical Research.
Development of various advance and novel vaccines for treatment of viral and bacterial infection during fish farming is the major driving factor of the market. Furthermore, various market players focusing on business strategies such as new product launches and collaboration to strengthen their market position will further boost the production of vaccines. Also, companies are investing in research and development programs for innovating aquaculture vaccines.
Increasing prevalence of viral and bacterial infection among aquaculture species across the Asia Pacific region is one of the major growth rendering factors, as aquaculture vaccines are most efficient form of treatment for various diseases. Moreover, various vaccines have been proven to be very efficacious in fish to prevent and protect them from bacteria and viruses.
The live aquaculture vaccines market in APAC accounted for more than USD 3.5 million revenue in 2020. Live vaccines are prepared from one or more bacteria or viruses displaying natural low virulence or attenuated virulence toward the target fish species. Pathogens can be attenuated using chemical and physical process, culture under normal conditions, serial passage in cell culture or genetic manipulation. Also, these live vaccines tend to be more immunogenic than inactivated vaccine preparations due to its ability to enter or proliferate host and stimulate greater cellular responses linked to both adaptive and innate immunity.
Immersion vaccines segment is expected to gather considerable gains of over 8.7% till 2027. Immersion vaccine dose during immersion are important to achieve good vaccine response. Immersion vaccination is preferred for mass vaccination of fish for high throughput injection vaccination. Moreover, several methods are been performed to increase immersion vaccine efficacy and safety.
Browse detailed statistical insights from the report, “Asia Pacific Aquaculture Vaccines Market Size By Route of Administration (Immersion Vaccines, Injection Vaccines, Oral Vaccines), By Type of Vaccines (Inactivated Vaccines, Live Vaccines), By Application (Bacterial Infection, Viral Infection), By Species (Salmon, Trout, Tilapia), Research Report, Country Outlook (China, Indonesia, Philippines, Thailand, Australia, New Zealand, Bangladesh, Vietnam, Taiwan, Malaysia), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027” along with the table of contents (ToC) @
Viral infection segment is projected to register exponential growth of over 8.5% through 2027. Viruses in aquaculture include infectious haematopoietic necrosis viruses, infectious haemorrhagic septicaemia virus and salmon anemia. These viral bacteria lead to heavy economic loss in the aquaculture farming and are the main cause of viral infection during aquaculture farming that will impel the segment growth. Furthermore, piscine orthoreovirus, covert mortality nodavirus and abalone herpesvirus are the few other viral bacteria that may cause severe damages to aquaculture industry.
Salmon segment size is poised to reach USD 4.2 million by 2027. Growing demand for salmon and its products owing to its capabilities against viral and bacterial infectious is expected to augment the segment demand. Also, salmon commercial vaccines are available for Japanese amberjack and yellowtail and channel catfish.
The Australia aquaculture vaccines market will show a significant growth of more than 8.5% from 2021 to 2027. High growth rate is owing to increasing prevalence of diseases in marline life, and technology development in aquaculture farming. For instance, according to the Australian fisheries and Aquaculture 2018 report, the aquaculture production volume increased by 4% to 97,672 tones. Furthermore, increasing R&D activities to develop innovative will further aid the industry growth.
The key players operating in aquaculture vaccines market are Zoetis Inc., HIPRA, Merck & Co., Inc., Tecnovax, Veterquimica S.A., and Virbac. among others. These companies focusing on various business strategies such as collaboration, geographic expansion to strengthen their market position. For instance, in January 2020, Barramundi Asia, a Singapore based company announced a merger with compatriot Allergo Aqua. The merger aimed to bring in-house fingerling R&D vaccination. This strategy is expected to maintain long-term business relations and outreach to untapped economies.
APAC aquaculture vaccines market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:
Asia Pacific Market, By Type of Vaccines, 2016-2027 (USD Million)
- Inactivated vaccine
- Live vaccine
Asia Pacific Market, By Route of Administration, 2016-2027 (USD Million)
- Immersion vaccines
- Injection vaccines
- Oral vaccines
Asia Pacific Market, By Application, 2016-2027 (USD Million)
- Bacterial infection
- Viral infection
Asia Pacific Market, By Species, 2016-2027 (USD Million)
The above information has been provided for the following countries:
- Asia Pacific
- New Zealand